GLOBULIN TEST, HUMAN THYROXINE BINDING— 510(k) K781225
Substantially EquivalentHyland Therapeutic Div., Travenol Laboratories
FDA 510(k) clearance K781225 for GLOBULIN TEST, HUMAN THYROXINE BINDING, Substantially Equivalent on 1978-08-31. Applicant: Hyland Therapeutic Div., Travenol Laboratories.
Clearance details
- Applicant
- Hyland Therapeutic Div., Travenol Laboratories
- Product code
- Code CEE
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.